Аг у взрослых. АГ у взрослых КР РФ 2019. Артериальная гипертензия у взрослых
 Скачать 0.71 Mb.
|
|
82. Sundstrom J, Lind L, Arnlov J, et al. Echocardiographic and electrocardiographic diagnoses of left ventricular hypertrophy predict mortality independently of each other in a population of elderly men. Circulation 2001;103:2346-51. Проект 83. Palmieri V, Dahlof B, DeQuattro V, et al. Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective Randomized Study Evaluating Regression of Ventricular Enlargement. J Am Coll Cardiol 1999;34:1625-32. 84. Levy D, Garrison RJ, Savage DO, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-6. 85. Perrone-Filardi P, Coca A, Galderisi M, et al. Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: a consensus paper from the European Association of Cardiovascular Imaging (EACVI), the European Society of Cardiology Council on Hypertension, and the European Society of Hypertension (ESH). Eur Heart J Cardiovasc Imaging 2017;18:945–960. 86. Aboyans V, Ricco JB, Bartelink MEL, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J 2017;39:763–816. 87. Ankle Brachial Index Collaboration. "Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis." JAMA: the journal of the American Medical Association 300.2 (2008): 197. 88. Breslin DJ, Gifford RW Jr, Fairbairn JF II, Kearns TP. Prognostic importance of ophthalmoscopic findings in essential hypertension. JAMA 1966;195:335–338. 89. Sairenchi T, Iso H, Yamagishi K, et al. Mild retinopathy is a risk factor for cardiovascular mortality in Japanese with and without hypertension: the Ibaraki Prefectural Health Study. Circulation 2011;124:2502–2511. 90. Dimmitt SB, West JN, Eames SM, et al. Usefulness of ophthalmoscopy in mild to moderate hypertension. Lancet 1989;1:1103–1106. 91. Longstreth WT Jr, Manolio TA, Arnold A, et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996;27:1274–1282. 92. Iadecola C, Yaffe K, Biller J, et al. American Heart Association Council on Hypertension, Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Quality of Care and Outcomes Research, Проект Stroke Council. Impact of hypertension on cognitive function: a scientific statement from the American Heart Association. Hypertension 2016;68:e67–e94. 93. Kearney-Schwartz A, Rossignol P, Bracard S, et al. Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints. Stroke 2009;40:1229–1236. 94. Tsoi KK, Chan JY, Hirai HW, et al. Cognitive tests to detect dementia: a systematic review and meta-analysis. JAMA Intern Med 2015;175:1450–1458. 95. Mach F., Baigent C., Catapano A. et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J 2019, published online on 31 August. 96. Lim GB. Hypertension: low sodium and DASH diet to lower blood pressure. Nat Rev Cardiol 2018;15:68. 97. Sundstrom J, Arima H, Jackson R, et al. Blood Pressure-Lowering Treatment Trialists’ Collaboration. Effects of blood pressure reduction in mild hypertension: a systematic review and meta-analysis. Ann Intern Med 2015;162:184–191. 98. Task FM, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016;37:2315–2381. 99. Thomopoulos C, Parati G, Zanchetti A. Effects of blood-pressure-lowering treatment on outcome incidence. 12. Effects in individuals with high-normal and normal blood pressure: overview and meta-analyses of randomized trials. J Hypertens 2017;35:2150–2160. 100. Beckett NS, Peters R, Fletcher AE, et al, HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008;358:1887–1898. 101. Thijs, Lutgarde, et al. A meta-analysis of outcome trials in elderly hypertensives. Journal of hypertension 10.10 (1992): 1103-1109. 102. Lonn EM, Bosch J, Lopez-Jaramillo P, et al., HOPE-3 Investigators. Blood-pressure lowering in. intermediate-risk persons without cardiovascular disease. N Engl J Med . 2016;374:2009–2020 103. Williamson JD, Supiano MA, Applegate WB, et al, SPRINT Research Group. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged >_75 years: a randomized clinical trial. JAMA 2016;315:2673–2682. Проект 104. Beckett N, Peters R, Leonetti G, Duggan J, Fagard R, Thijs L, Narkiewicz K,McCormack T, Banya W, Fletcher A, Bulpitt C, HYVET Study Group. Subgroup and per-protocol analyses from the Hypertension in the Very Elderly Trial. J Hypertens 2014;32:1478–1487. 105. Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on . outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials. J Hypertens 2014;32:2285–2295. 106. Patel A, ADVANCE Collaborative Group, MacMahon S, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007;370:829–840.] 107. Thomopoulos C, Parati G, Zanchetti A. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials. J Hypertens 2017;35:922–944. 108. Odden MC, McClure LA, Sawaya BP, et al. Achieved blood pressure and outcomes in the Secondary Prevention of Small Subcortical Strokes Trial. Hypertension 2016;67:63–69. 109. Prospective Studies Collaboration et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies //The Lancet. – 2002. – Т. 360. – №. 9349. – С. 1903-1913. 110. Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels - updated overview and meta-analyses of randomized trials. J Hypertens 2016;34:613–622. 111. Bohm M, Schumacher H, Teo KK, et al. Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from . ONTARGET and TRANSCEND trials. Lancet 2017;389:2226–2237. 112. Kjeldsen SE, Berge E, Bangalore S, et al. No evidence for a J-shaped . curve in treated hypertensive patients with increased cardiovascular risk: The . VALUE trial. Blood Press 2016;25:83–92. 113. Mancia G, Kjeldsen SE, Zappe DH, et al. Cardiovascular outcomes at different on treatment blood pressures in the hypertensive patients of the VALUE trial. Eur Heart J . 2016;37:955–964. 114. Dickinson HO, Mason JM, Nicolson DJ, et al. Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. J Hypertens 2006;24:215–233. Проект 115. Lim, Stephen S., et al. "A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010." The lancet 380.9859 (2012): 2224- 2260. 116. He FJ, Li J, Macgregor GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev 2013;4:CD004937. 117. Graudal NA, Hubeck-Graudal T, Jurgens G. Effects of low-sodium diet vs. highsodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride (Cochrane Review). Am J Hypertens 2012;25:1–15. 118. Taylor RS, Ashton KE, Moxham T, et al. Reduced dietary salt for the prevention of cardiovascular disease: a meta-analysis of randomized controlled trials (Cochrane review). Am J Hypertens 2011;24:843–853. 119. Aburto NJ, Ziolkovska A, Hooper L, et al. Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ 2013;346:f1326. 120. Xin, Xue, et al. "Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials." Hypertension 38.5 (2001): 1112-1117. 121. Estruch R, Ros E, Salas-Salvado J, et al. PREDIMED Study Investigators. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013;368:1279–1290. 122. Neter JE, Stam BE, Kok FJ, et al. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials.Hypertension 2003;42:878–884. 123. Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 2013;309:71–82. 124. Berrington de Gonzalez, Amy, et al. "Body-mass index and mortality among 1.46 million white adults." New England Journal of Medicine 363.23 (2010): 2211-2219. 125. Leitzmann, Michael F., et al. "Physical activity recommendations and decreased risk of mortality." Archives of internal medicine 167.22 (2007): 2453-2460. 126. Rossi, Amanda, et al. "The impact of physical activity on mortality in patients with high blood pressure: a systematic review." Journal of hypertension 30.7 (2012): 1277-1288. 127. Shinton, Roger, and Gareth Beevers. "Meta-analysis of relation between cigarette smoking and stroke." Bmj 298.6676 (1989): 789-794. 128. He, Jiang, et al. "Passive smoking and the risk of coronary heart disease—a meta-analysis of epidemiologic studies." New England Journal of Medicine 340.12 (1999): 920-926. |